Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$412M |
| 2 |
Advanced Micro Devices
AMD
|
+$294M |
| 3 |
Apple
AAPL
|
+$244M |
| 4 |
Qualcomm
QCOM
|
+$207M |
| 5 |
Pinduoduo
PDD
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$510M |
| 2 |
Uber
UBER
|
+$419M |
| 3 |
Chevron
CVX
|
+$286M |
| 4 |
Meta Platforms (Facebook)
META
|
+$255M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.64% |
| 2 | Healthcare | 18.28% |
| 3 | Consumer Discretionary | 13.73% |
| 4 | Industrials | 8.66% |
| 5 | Financials | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Gossamer Bio
GOSS
$82.9M
| $1.84M | ﹤0.01% |
2,046,600
+1,375,000
| +205% | +$1.03M |
|
|
CHMI
1927
Cherry Hill Mortgage Investment Corp
CHMI
$83M
| $1.84M | ﹤0.01% |
507,684
+37,300
| +8% | +$134K |
|
1928
Laird Superfood
LSF
$45.8M
| $1.84M | ﹤0.01% |
327,600
+151,679
| +86% | +$459K |
|
1929
Adicet Bio
ACET
$85.2M
| $1.83M | ﹤0.01% |
94,538
+28,975
| +44% | +$776K |
|
|
ACCD
1930
DELISTED
Accolade Inc
ACCD
| $1.83M | ﹤0.01% |
510,700
+800
| +0.2% | +$6.06K |
|
1931
First Financial Bankshares
FFIN
$5.04B
| $1.83M | ﹤0.01% |
+61,808
| New | +$1.85M |
|
1932
Third Coast Bancshares
TCBX
$729M
| $1.82M | ﹤0.01% |
85,505
+9,105
| +12% | +$183K |
|
1933
Invesco Taxable Municipal Bond ETF
BAB
$1.02B
| $1.82M | ﹤0.01% |
+68,931
| New | +$1.81M |
|
1934
BK Technologies
BKTI
$300M
| $1.82M | ﹤0.01% |
141,816
+48,838
| +53% | +$667K |
|
1935
Fidelity Nasdaq Composite Index ETF
ONEQ
$10.4B
| $1.81M | ﹤0.01% |
25,900
+6,100
| +31% | +$399K |
|
1936
Pacer US Cash Cows 100 ETF
COWZ
$18.8B
| $1.81M | ﹤0.01% |
33,200
-7,800
| -19% | -$433K |
|
1937
Invesco BulletShares 2027 Corporate Bond ETF
BSCR
$4.59B
| $1.81M | ﹤0.01% |
94,065
+58,563
| +165% | +$1.12M |
|
1938
McEwen Inc
MUX
$1.03B
| $1.81M | ﹤0.01% |
196,910
+57,600
| +41% | +$633K |
|
1939
Caesarstone
CSTE
$72.3M
| $1.81M | ﹤0.01% |
361,218
-66,060
| -15% | -$374K |
|
1940
Schwab 1000 Index ETF
SCHK
$5.71B
| $1.81M | ﹤0.01% |
69,000
-57,000
| -45% | -$1.44M |
|
1941
Community Health Systems
CYH
$393M
| $1.8M | ﹤0.01% |
537,093
+283,500
| +112% | +$954K |
|
1942
Loar Holdings
LOAR
$6.41B
| $1.8M | ﹤0.01% |
+33,700
| New | +$1.83M |
|
1943
Fate Therapeutics
FATE
$286M
| $1.8M | ﹤0.01% |
+548,544
| New | +$2.4M |
|
1944
VanEck Oil Services ETF
OIH
$2.06B
| $1.8M | ﹤0.01% |
5,690
-8,000
| -58% | -$2.56M |
|
|
GBIO
1945
DELISTED
Generation Bio
GBIO
| $1.79M | ﹤0.01% |
63,640
-2,810
| -4% | -$91.3K |
|
|
CFB
1946
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $1.79M | ﹤0.01% |
127,800
+14,800
| +13% | +$191K |
|
1947
Kraft Heinz
KHC
$30.7B
| $1.79M | ﹤0.01% |
55,600
-54,300
| -49% | -$1.94M |
|
1948
Olin
OLN
$2.11B
| $1.78M | ﹤0.01% |
37,800
-60,000
| -61% | -$3.21M |
|
1949
Standard BioTools
LAB
$340M
| $1.78M | ﹤0.01% |
1,004,558
-249,300
| -20% | -$609K |
|
1950
Ranger Energy Services
RNGR
$376M
| $1.77M | ﹤0.01% |
168,390
+7,700
| +5% | +$81.1K |
|
Similar funds
Renaissance Technologies's Q2 2024 Portfolio in Review
As of Q2 2024, Renaissance Technologies held 4,123 positions worth $59B, down 7.3% from $63.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $4.49B in Q2 2024, closing 675 positions and reducing 1,503 holdings. Its most notable exit was Bank of America, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Broadcom worth $472M.
- Renaissance Technologies's largest Q2 2024 buy was Broadcom: 2,941,150 shares worth $472M.
- Renaissance Technologies added most to Apple in Q2 2024, an estimated $244M increase.
- Renaissance Technologies's biggest Q2 2024 reduction was Amazon, cutting an estimated $510M.
- Renaissance Technologies fully exited Bank of America in Q2 2024, selling an estimated $142M.
- Renaissance Technologies's ten largest holdings make up 12% of its $59B portfolio in Q2 2024.
- Renaissance Technologies opened 463 new positions and closed 675 in Q2 2024.
- Renaissance Technologies's portfolio value fell 7.3% quarter-over-quarter to $59B.
Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.